Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CARA TSE:MTY NYSEARCA:PZA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCARACara Therapeutics$15.19$8.13▼$19.08$24.33M0.4122,224 shs237,144 shsMTYMTY Food GroupC$38.44-0.4%C$39.46C$36.79▼C$53.16C$878.01M1.15683360,240 shs65,598 shsPZAInvesco National AMT-Free Municipal Bond ETF$22.99-0.1%$22.24$21.49▼$24.34$2.93B0.191.59 million shs666,285 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCARACara Therapeutics0.00%0.00%0.00%0.00%+51.05%MTYMTY Food Group-0.39%-1.23%-2.19%-4.73%-8.15%PZAInvesco National AMT-Free Municipal Bond ETF-0.13%+1.91%+3.28%+2.91%-4.80%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCARACara Therapeutics$15.19$8.13▼$19.08$24.33M0.4122,224 shs237,144 shsMTYMTY Food GroupC$38.44-0.4%C$39.46C$36.79▼C$53.16C$878.01M1.15683360,240 shs65,598 shsPZAInvesco National AMT-Free Municipal Bond ETF$22.99-0.1%$22.24$21.49▼$24.34$2.93B0.191.59 million shs666,285 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCARACara Therapeutics0.00%0.00%0.00%0.00%+51.05%MTYMTY Food Group-0.39%-1.23%-2.19%-4.73%-8.15%PZAInvesco National AMT-Free Municipal Bond ETF-0.13%+1.91%+3.28%+2.91%-4.80%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCARACara Therapeutics 0.00N/AN/AN/AMTYMTY Food Group 2.33HoldC$50.5031.37% UpsidePZAInvesco National AMT-Free Municipal Bond ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest PZA, CARA, and MTY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/14/2025MTYMTY Food GroupAcumen CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuyC$60.00 ➝ C$50.007/14/2025MTYMTY Food GroupRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetC$51.00 ➝ C$48.006/18/2025MTYMTY Food GroupScotiabankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold(Data available from 9/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCARACara Therapeutics$7.14M0.00N/AN/A$12.58 per share0.00MTYMTY Food GroupC$1.17B0.75C$1.45 per share26.52C$35.02 per share1.10PZAInvesco National AMT-Free Municipal Bond ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCARACara Therapeutics-$118.51M-$21.01N/AN/AN/A-1,099.76%-367.97%-107.43%N/AMTYMTY Food GroupC$93.69MC$1.7222.35∞0.758.30%11.66%4.18%N/APZAInvesco National AMT-Free Municipal Bond ETFN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCARACara TherapeuticsN/AN/AN/AN/AN/AMTYMTY Food GroupC$1.223.17%N/A70.93%N/APZAInvesco National AMT-Free Municipal Bond ETF$0.793.44%N/AN/AN/ALatest PZA, CARA, and MTY DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/5/2025MTYMTY Food GroupQuarterlyC$0.333.25%8/5/20258/15/20258/15/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCARACara TherapeuticsN/A4.774.71MTYMTY Food Group142.670.610.57PZAInvesco National AMT-Free Municipal Bond ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCARACara Therapeutics44.66%MTYMTY Food Group22.88%PZAInvesco National AMT-Free Municipal Bond ETFN/AInsider OwnershipCompanyInsider OwnershipCARACara Therapeutics3.10%MTYMTY Food Group16.54%PZAInvesco National AMT-Free Municipal Bond ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCARACara Therapeutics804.57 million4.43 millionOptionableMTYMTY Food Group7,32622.84 millionN/ANot OptionablePZAInvesco National AMT-Free Municipal Bond ETFN/A127.25 millionN/ANot OptionablePZA, CARA, and MTY HeadlinesRecent News About These CompaniesPZA - Wholly Sensible But The Results Are DisappointingSeptember 10 at 8:01 AM | seekingalpha.comInvesco AMT-Free Municipal Inc CApril 26, 2025 | morningstar.comMInvesco National AMT-Free Municipal Bond ETF declares monthly distribution of $0.0662March 25, 2025 | msn.comInvesco National AMT-Free Municipal Bond ETF declares monthly distribution of $0.0629February 26, 2025 | seekingalpha.comPZA Invesco National AMT-Free Municipal Bond ETFJanuary 25, 2025 | seekingalpha.comInvesco National AMT-Free Municipal Bond ETF declares monthly distribution of $0.06499January 21, 2025 | msn.comInvesco National AMT-Free Municipal Bond ETF declares monthly distribution of $0.0641December 23, 2024 | msn.comInvesco National AMT-Free Muni Bd ETFDecember 19, 2024 | morningstar.comM(PZA) Trading SignalsDecember 1, 2024 | news.stocktradersdaily.comNPWZ Invesco California AMT-Free Municipal Bond ETFNovember 21, 2024 | seekingalpha.com(PZA) Investment Analysis and AdviceNovember 21, 2024 | news.stocktradersdaily.comNLong Term Trading Analysis for (PZA)November 11, 2024 | news.stocktradersdaily.comNThese 4 Invesco Fixed Income ETFs Seeing Strong Investor InterestNovember 6, 2024 | etftrends.comEWealth managers eyeing municipal bonds ahead of tax cut sunsetsOctober 30, 2024 | investmentnews.comI(PZA) Technical DataOctober 30, 2024 | news.stocktradersdaily.comNHow the (PZA) price action is used to our AdvantageOctober 19, 2024 | news.stocktradersdaily.comN(PZA) Trading AdviceOctober 10, 2024 | news.stocktradersdaily.comNiShares National Muni Bond ETF declares monthly distribution of $0.275861October 3, 2024 | msn.com(PZA) On The My Stocks PageSeptember 28, 2024 | news.stocktradersdaily.comNInvesco New York AMT-Free Municipal Bond ETF declares monthly distribution of $0.0594September 24, 2024 | msn.comMedia Sentiment Over TimePZA, CARA, and MTY Company DescriptionsCara Therapeutics NASDAQ:CARACara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.MTY Food Group TSE:MTYC$38.44 -0.15 (-0.39%) As of 09/12/2025 04:00 PM EasternMTY Food Group Inc is a franchisor in the quick service and casual dining food industry. Its activities consist of franchising and operating corporate-owned locations as well as the sale of retail products under a multitude of banners. The company's operating segment is based on geographical regions namely Canada and US and International. It generates maximum revenue from Canada. The company brands include Big Smoke Burger, Cafe Depot, Country Style, Croissant Plus, Cultures, Extremepita, Fabrika, Jus Jugo Juice, Koya Japan, ManchuWok, Muffin plus, Valentine, Van Houtte, Shushiman and others.Invesco National AMT-Free Municipal Bond ETF NYSEARCA:PZA$22.99 -0.03 (-0.13%) Closing price 09/12/2025 04:10 PM EasternExtended Trading$22.98 0.00 (-0.02%) As of 09/12/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Invesco National AMT-Free Municipal Bond ETF (PZA) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks an index of investment grade, tax-exempt debt publicly issued by a US state with at least 15 years remaining to maturity. PZA was launched on Oct 11, 2007 and is managed by Invesco. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Tesla's U.S. Market Is At An 8-Year Low... How Bad Could It Get? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
